Tola Esra Nur, Yalcin Serenat Eris, Dugan Nadiye
Department of Obstetrics and Gynecology, Suleyman Demirel University, Faculty of Medicine, Isparta, Turkey.
Department of Obstetrics and Gynecology, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:168-172. doi: 10.1016/j.ejogrb.2017.05.014. Epub 2017 May 15.
OBJECTIVE(S): The aim of our study is to analyse the inflammatory markers and lipid accumulation product (LAP) index in nonobese adolescents and younger aged women with polycystic ovary syndrome (PCOS) compared with age and body mass index (BMI)-matched healthy controls and to determine whether the investigated parameters are potential markers for the etiopathogenesis of PCOS. We also aim to determine whether these inflammatory markers are predictive for developing some clinical implications, such as cardiovascular disease (CVD) and insulin resistance (IR), associated with PCOS.
A total of 34 adolescents and younger aged females with PCOS, and 33 age and BMI-matched healthy controls were recruited for our study. All participants were nonobese (BMI<25). Neopterin (NEO), C-reactive protein (CRP) levels and complete blood parameters were assessed. LAP index and homeostasis model assessment of IR (HOMA-IR) were calculated; anthropometric, clinical and biochemical parameters were also recorded.
Serum NEO, CRP levels and LAP index were significantly increased in nonobese adolescents and younger aged females with PCOS compared to healthy controls. We could not found any predictive effect of investigated inflammatory markers and LAP index on CVD risk among PCOS patients after adjustment for abdominal obesity. We also found a positive predictive effect of WBC and a negative predictive effect of lymphocytes on IR in PCOS patients after adjustment for abdominal obesity. We did not find any predictor effect of NEO on IR, but it was a positive predictive marker for an elevated HOMA-IR index.
CONCLUSION(S): Elevated NEO, CRP levels and LAP index could have potential roles in the etiopathogenesis of PCOS in nonobese adolescents and younger aged females,NEO could be a predictive marker for elevated HOMA-IR index, and WBC and lymphocytes could be predictive for the development of IR among nonobese adolescents and younger aged females with PCOS.
我们研究的目的是分析非肥胖青少年及年轻女性多囊卵巢综合征(PCOS)患者的炎症标志物和脂质蓄积产物(LAP)指数,并与年龄和体重指数(BMI)匹配的健康对照进行比较,以确定所研究的参数是否为PCOS发病机制的潜在标志物。我们还旨在确定这些炎症标志物是否可预测与PCOS相关的一些临床后果,如心血管疾病(CVD)和胰岛素抵抗(IR)。
我们招募了34名患有PCOS的青少年及年轻女性,以及33名年龄和BMI匹配的健康对照进行研究。所有参与者均非肥胖(BMI<25)。评估了新蝶呤(NEO)、C反应蛋白(CRP)水平及全血参数。计算了LAP指数和IR的稳态模型评估(HOMA-IR);还记录了人体测量、临床和生化参数。
与健康对照相比,非肥胖青少年及年轻女性PCOS患者的血清NEO、CRP水平和LAP指数显著升高。在调整腹部肥胖后,我们未发现所研究的炎症标志物和LAP指数对PCOS患者CVD风险有任何预测作用。在调整腹部肥胖后,我们还发现PCOS患者中白细胞(WBC)对IR有正向预测作用,淋巴细胞对IR有负向预测作用。我们未发现NEO对IR有任何预测作用,但它是HOMA-IR指数升高的正向预测标志物。
NEO、CRP水平升高和LAP指数可能在非肥胖青少年及年轻女性PCOS的发病机制中起潜在作用,NEO可能是HOMA-IR指数升高的预测标志物,而WBC和淋巴细胞可能预测非肥胖青少年及年轻女性PCOS患者IR的发生。